1Yasuda T,Mochizuki H.Recent advances in cell and gene therapies for Parkinsons disease[J].Nippon Rinsho,2009,67(7):1429-1438.
2Elahi B,Elahi B,Chen R.Effect of transcranial magnetic stimulation on Parkinson motor function-systematic review of controlled clinical trials[J].Mov Disord,2009,24(3):357-363.
3Lou JS.Physical and mental fatigue in Parkinsons disease:epidemiology,pathophysiology and treatment[J].Drugs Aging,2009,26(3):195-208.
4Lefauaheur JP.Motor cortex dysfunction revealed by cortical excitability studies in Parkinsons disease:influence of antiparkinsonian treatment and cortical stimulation[J].Clin Neurophysiol,2005,116(2):244-253.
5Hamada M,Ugawa Y,Tsuji S,et al.High-frequency rTMS over the supplementary motor area for treatment of Parkinson's disease[J].Mov Disord,2008,23(11):1524-1531.
6Khedr EM,Farweez HM,Islam H.Therapeutic effect of repetitive transcranial magnetic stimulation on motor function in Parkinsons disease patients[J].Eur J Neurol,2003,10(5):567-572.
7Boylan LS,Pulhnan SI,Lisanby SH,et al.Repetitive transcranial magnetic stimulation to SMA worsens complex movements in Parkinsons disease[J].Clin Neurophysiol,2001,112(2):259-264.
8Benninger DH,Lomarev M,Wassermann EM,et al.Safety study of 50 Hz repetitive transcranial magnetic stimulation in patients with Parkinsons disease[J].Clin Neurophysiol,2009,120(4):809-815.
7Schuurman AG,vanden Akker M,Ensinck KT,et al.Increased risk ofParkinson/ s disease after depression :a retrospective cohort study [J].Neuorlogy,2002,58(10):1501-1504.
8Nutt JC, Woodwand WR, Hamnmerstad JP, et al. The " on-off" phenmen on in Parkinsoms disease. Relation to levodopa absorption and transport. JM, 1984,310:483-485.
